Logo
Banner

Anti-Superbug Drugs Development

Superbugs, also known as antibiotic-resistant bacteria, are strains of bacteria that have developed the ability to resist the effects of traditional antibiotics. This poses a significant threat to public health, as infections caused by superbugs are more difficult to treat and can lead to higher morbidity and mortality rates. To combat this threat, researchers and pharmaceutical companies have been developing new drugs to fight these superbugs.

Ace Infectious is a biotechnology company focused on superbug research to discuss the latest advances in anti-superbug drug and therapy development. We offer a variety of development services for superbugs, including antimicrobial peptides, antibiotic adjuvants, antibodies, phages, and vaccines.

Our Anti-Superbug Drug Development Services

Our development services are comprehensive and specific, and you can click on the headings below to view each development service for more details.

Antimicrobial Peptides Development

Some promising natural product candidates are antimicrobial peptides (AMPs) from various organisms, which represent some of the possible solutions against superbugs. Our service is to help researchers find natural AMPs, explore their mechanisms of antimicrobial activity, and optimize antimicrobial activity and minimize toxicity and production costs, using AMP as a natural model for developing novel antibiotics in the future.

Antibiotic Adjuvants Development

Small molecule antibiotic adjuvants work by hindering the bacterial resistance mechanism and making the bacteria sensitive to antibiotics. We offer several services for developing potential antibiotic adjuvants, including adjuvants that inhibit the degradation of antibiotics by β-lactamases, modulate the permeability of bacterial extracellular membranes, or increase the intracellular concentration of antibiotics by inhibiting efflux.

Monoclonal Antibodies Development Against Superbugs

Monoclonal antibodies can treat bacterial infections by a variety of mechanisms and are often safe and well-tolerated. Antibodies complement antibiotic therapy and have efficacy against resistant strains of bacteria. We offer services for the development of exciting next generation antibodies against superbugs, which include antibodies with different mechanisms of action and different forms of antibodies designed.

Phage Therapies Development Against Superbugs

In the context of today's progressive rise in antibiotic resistance, phages are increasingly being used to treat chronic bacterial infections that have become resistant to multiple antibiotics. We provide development services including phage discovery, isolation, characterization, cocktail design, engineering, and preclinical development programs for phage drug discovery.

Development of Vaccine Against Superbugs

The development of vaccines against superbugs is an important area of research because vaccines can help prevent infections from occurring in the first place and reduce the need for antibiotics. We provide development services of vaccine against superbugs with fast turnaround times, cost-effectiveness, and unparalleled technical expertise.

Start Your Superbug Project

Developing drugs against superbugs is a complex and challenging process. If you need to start and run your project smoothly, you may need our broad range of development capabilities.

  • Expertise in microbiology
  • Expertise in medicinal chemistry
  • Expertise in pharmacology and toxicology
Would you like to learn more about our superbug research? If so, contact us now and start your superbug project!
All of our services are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Get in touch with our team immediately.